biospecimen__admin__batch_number	425.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	3BE12C86-C15A-479F-996E-1EB20B114D9B
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AAEE-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AAEE-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AAEE-01A
biospecimen__bio__biospecimen_barcode_bottom	0174164288
biospecimen__bio__day_of_creation	09
biospecimen__bio__day_of_shipment	28
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-AAEE.D857BF5A-E2C6-4A6E-88CA-E8707E6FF3D9.pdf
biospecimen__bio__plate_column	9
biospecimen__bio__plate_id	A41H
biospecimen__bio__plate_row	F
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AAEE
biospecimen__shared__patient_id	AAEE
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-DD-AAEE-A68428
clinical__ablation__bcr_ablation_uuid	824D8AAC-0C3D-40A8-8091-A0704D0DC6DC
clinical__ablation__days_to_embolization_performed	551
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Other
clinical__ablation__embolization_therapy_drug_name_other	adriamycin
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Gelfoam
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	BECDCC68-C055-4918-A523-5AF95D09F6B1
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	4.7
clinical__chol_lihc_shared__albumin_result_upper_limit	5.3
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.8
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	3
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	1.0
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.0
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	55
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-AAEE-F68427
clinical__clin_shared__bcr_followup_uuid	2A9EE485-30AC-497E-B631-E5EB8B8BDA3D
clinical__clin_shared__day_of_form_completion	17
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	221
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2012
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	YES
clinical__nte__days_to_new_tumor_event_additional_surgery_procedure	298
clinical__nte__days_to_new_tumor_event_after_initial_treatment	224
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__nte__residual_disease_post_new_tumor_event_margin_status	RX
clinical__rad__anatomic_treatment_site	Distant Recurrence
clinical__rad__bcr_radiation_barcode	TCGA-DD-AAEE-R68429
clinical__rad__bcr_radiation_uuid	F6970A06-9B74-4957-9847-E8385B837BE3
clinical__rad__days_to_radiation_therapy_end	692
clinical__rad__days_to_radiation_therapy_start	595
clinical__rad__numfractions	2
clinical__rad__radiation_dosage	14000
clinical__rad__radiation_treatment_ongoing	NO
clinical__rad__radiation_type	External
clinical__rad__units	cGy
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G4
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	a239751f-1975-4791-a9bc-b5ba8de127fd
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AAEE-01A-11R-A41H-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	c43653f9-dda9-4afe-b219-cb975c4af831
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	41c55504-41d6-43f0-aa6b-17b10bc52c8a
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	3c51fee0-da54-40e9-a954-dfe30f6f075c
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:29:32.212662-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	0b63d5fa-7cd3-52d9-9b91-c4233217b640
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1957
gdc__diagnoses__age_at_diagnosis	20396
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-20396.0
gdc__diagnoses__days_to_last_follow_up	810.0
gdc__diagnoses__diagnosis_id	57265c3b-99b8-5c32-afd5-e9ef437df17f
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	22.65625
gdc__exposures__exposure_id	994d40e2-442f-5b46-926b-fd2ecda04a3b
gdc__exposures__height	160.0
gdc__exposures__weight	58.0
gdc__file_id	0f5c1ab7-f4bc-44eb-8b21-992e916aa2ab
gdc__file_name	170b2ffd-eae5-42d1-bfcd-6f5cbc6778cd.mirbase21.mirnas.quantification.txt
gdc__file_size	50170
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	15013ce9be6ebcb1fe1d073d65e5d888
gdc__portions__is_ffpe	false
gdc__portions__portion_id	cd7a4302-2e7f-496c-863d-a1a5a00a2437
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	509
gdc__samples__initial_weight	40.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	D857BF5A-E2C6-4A6E-88CA-E8707E6FF3D9
gdc__samples__sample_id	2df88392-7502-4dfe-8f51-7334f363883e
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	a59a0c0c-a433-47af-963a-c67a94a05107
gdc__submitter_id	mirna_swap_dr11_28_MirnaExpression1e85e8a6-1d26-4ef0-9df9-f98c40a02eef_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	252fbca6-d8f3-519e-afe2-10f4b6cfbc24
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:10:16.680+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a239751f-1975-4791-a9bc-b5ba8de127fd-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a239751f-1975-4791-a9bc-b5ba8de127fd-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129541
manually_curated__local_md5	ea29fd504aa7ebd350eaebbbe0f365f1
manually_curated__opengdc_download_date	2018-10-16T17:10:00.000367+02:00
manually_curated__opengdc_file_md5	d68193ae33765a89ba47e057f1ca88a4
manually_curated__opengdc_file_size	50169
manually_curated__opengdc_id	a239751f-1975-4791-a9bc-b5ba8de127fd-meq
manually_curated__origin_file_size	129541
manually_curated__origin_last_modified_date	Tue Oct 16 17:16:00 CEST 2018
manually_curated__origin_md5	ea29fd504aa7ebd350eaebbbe0f365f1
manually_curated__tissue_status	tumoral
